199 related articles for article (PubMed ID: 1507584)
1. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
Rhim BY; Lee WS; Hong KW
Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
[No Abstract] [Full Text] [Related]
2. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
Triggle CR; Li YQ; Wyse DG
Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
[No Abstract] [Full Text] [Related]
3. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
la Rochelle CD; Richard V; Dubois-Randé JL; Roupie E; Giudicelli JF; Hittinger L; Berdeaux A
J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
Weston AH
Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
[No Abstract] [Full Text] [Related]
6. The effect of intracavernous injection of potassium channel openers in monkeys and dogs.
Trigo-Rocha F; Donatucci CF; Hsu GL; Nunes L; Lue TF; Tanagho EA
Int J Impot Res; 1995 Mar; 7(1):41-8. PubMed ID: 7670592
[TBL] [Abstract][Full Text] [Related]
7. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
Wu Y; Fang D
Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):180-3. PubMed ID: 1319810
[No Abstract] [Full Text] [Related]
8. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
Stockbridge N; Zhang H; Weir B
Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
[TBL] [Abstract][Full Text] [Related]
9. Cromakalim, pinacidil and RP 49356 activate a tolbutamide-sensitive K+ conductance in human skeletal muscle fibres.
Quasthoff S; Spuler A; Lehmann-Horn F; Grafe P
Pflugers Arch; 1989; 414 Suppl 1():S179-80. PubMed ID: 2780252
[No Abstract] [Full Text] [Related]
10. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return.
Gotanda K; Yokoyama H; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Aug; 3(4):507-15. PubMed ID: 2488102
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
[TBL] [Abstract][Full Text] [Related]
12. K+ channel openers delay intestinal transit and have antidiarrheal activity.
Poggioli R; Benelli A; Arletti R; Cavazzuti E; Bertolini A
Eur J Pharmacol; 1995 Dec; 287(2):207-9. PubMed ID: 8749038
[TBL] [Abstract][Full Text] [Related]
13. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
Iwamoto T; Nishimura N; Morita T; Sukamoto T
J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
[TBL] [Abstract][Full Text] [Related]
14. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
Wahl M; Parsons AA; Schilling L
Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
Taylor SG; Arch JR; Bond J; Buckle DR; Shaw DJ; Taylor JF; Ward JS
J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358
[TBL] [Abstract][Full Text] [Related]
16. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
Matsumoto H; Nakano H; Akiba Y; Osanai S; Tobise K; Onodera S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1488-95. PubMed ID: 1434222
[TBL] [Abstract][Full Text] [Related]
17. Modulation of intracellular calcium by potassium channel openers in vascular muscle.
Erne P; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):706-15. PubMed ID: 1775202
[TBL] [Abstract][Full Text] [Related]
18. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
Satoh K
Nihon Rinsho; 1993 May; 51(5):1293-8. PubMed ID: 8331797
[TBL] [Abstract][Full Text] [Related]
19. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
Gelband GH; McCullough JR
Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
